Nexium Is Part Of Anti-Competitive Plan To Thwart Generic Prilosec, Retailer Suit Against AstraZeneca Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Walgreen’s, Eckerd and Kroger are among the retailers filing suit against AstraZeneca over the launch of the Prilosec follow-on Nexium.
You may also be interested in...
The Price Is Not Right: AstraZeneca Puts Nexium On Sale
Marketing shift will target branded proton pump inhibitors for market share gains rather than generic Prilosec.
The Price Is Not Right: AstraZeneca Puts Nexium On Sale
Marketing shift will target branded proton pump inhibitors for market share gains rather than generic Prilosec.
AstraZeneca’s New Head Of Strategic Planning & Business Development John Goddard: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
AstraZeneca looking to improve how it manages deals, Goddard says.